Anti-Aβ antibodies and antigen-binding fragments thereof
US12325741B2 · kind B2 · utility
0Cited by
4References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 16, 2019 |
| Grant date | Jun 10, 2025 |
| Priority date | — |
| Expiry date | Oct 8, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Murine, chimeric or humanized anti-Abeta antibody having a specific CDR region, an antigen-binding fragment thereof, a pharmaceutical composition thereof, and usage thereof. Use of a humanized anti-Abeta antibody for the preparation of drugs for the treatment of a disease or disorder (such as Alzheimer's disease) caused by amyloid beta protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.